Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension

被引:13
|
作者
Zhang, Duan-zhen [1 ]
Zhu, Xian-yang [1 ]
Meng, Jing [1 ]
Xue, Hong-mei [1 ]
Sheng, Xiao-tang [1 ]
Han, Xiu-min [1 ]
Cui, Chun-Sheng [1 ]
Wang, Qi-guang [1 ]
Zhang, Po [1 ]
机构
[1] Shenyang No Hosp, Dept Congenital Heart Dis, Shenyang 110016, Peoples R China
关键词
Pulmonary arterial hypertension; Vasoreactivity test; Hemodynamics; Congenital heart defect; INHALED NITRIC-OXIDE; AEROSOLIZED ILOPROST; VASODILATOR CAPACITY; VASCULAR-RESISTANCE; DISEASE; CHILDREN; THERAPY; BOSENTAN; GUIDELINES;
D O I
10.1016/j.ijcard.2010.04.093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Detection of pulmonary vasoreactivity is important for the evaluation of patient with pulmonary arterial hypertension (PAH). The present study aimed to investigate the acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects (CHDs) and severe PAH. Patients and methods: From Mar 2007 to Nov 2009, 75 patients with severe PAH secondary to left-to-right shunt CHDs underwent acute vasodilator test using aerosolized iloprost (n=50) or intravenous adenosine (n=25). The hemodynamics were detected and analyzed. Results: Decreased mean pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) were observed in 39 and 43 patients in the iloprost group, and in 16 and 19 patients in the adenosine group, respectively. However, the mean PAP was higher than 40 mm Hg in both groups. No significant difference was observed in the age and baseline hemodynamics between the patients with the decrease of PVR and mean pulmonary-to-aortic pressure (Pp/Ps) ratio greater than 10% and the remaining patients. Adenosine decreased both PAP and systemic arterial pressure significantly, while iloprost inhalation selectively reduced the PAP and increased the oxygen saturation of femoral arterial blood and the pulmonary-to-systemic flow (Qp/Qs) ratio. Compared with adenosine, iloprost caused a more profound decline in the Pp/Ps ratio, PVR and pulmonary-to-systemic vascular resistance ratio, and increase in the Qp/Qs ratio. Conclusions: The acute haemodynamic responses to adenosine and iloprost varied among the patients with CHDs and severe PAH. Different to adenosine, inhaled iloprost exerted selective pulmonary vasodilative effects and was beneficial for pulmonary gas exchange. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:433 / 437
页数:5
相关论文
共 50 条
  • [41] Impact of long lasting pulmonary arterial hypertension on the surgery of congenital heart defect
    Nya, Fouad
    Ahchouch, Sara
    Mokhlis, Houda
    Amri, Rachida
    Bouaiti, El arbi
    Bamous, Mehdi
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2024, 74
  • [42] Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism
    Duffels, M. G. J.
    van der Plas, M. N.
    Surie, S.
    Winter, M. M.
    Bouma, B. J.
    Groenink, M.
    van Dijk, A. P. J.
    Hoendermis, E. S.
    Berger, R. M. F.
    Bresser, P.
    Mulder, B. J. M.
    NETHERLANDS HEART JOURNAL, 2009, 17 (09) : 334 - +
  • [43] Riociguat for pulmonary arterial hypertension associated with congenital heart disease
    Rosenkranz, Stephan
    Ghofrani, Hossein-Ardeschir
    Beghetti, Maurice
    Ivy, Dunbar
    Frey, Reiner
    Fritsch, Arno
    Weimann, Gerrit
    Saleh, Soundos
    Apitz, Christian
    HEART, 2015, 101 (22) : 1792 - U41
  • [44] Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
    Gatzoulis, M. A.
    Alonso-Gonzalez, R.
    Beghetti, M.
    EUROPEAN RESPIRATORY REVIEW, 2009, 18 (113) : 154 - 161
  • [45] Modeling of pharmacokinetics, efficacy, and hemodynamic effects of macitentan in patients with pulmonary arterial hypertension
    Krause, Andreas
    Zisowsky, Jochen
    Dingemanse, Jasper
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 49 : 140 - 146
  • [46] Acute hemodynamic effect of inhaled iloprost in pulmonary artery hypertension evaluated with echocardiography
    Loureiro M.J.
    Cotrim C.
    Simões O.
    Miranda R.
    Cordeiro P.
    Carrageta M.
    Cardiovascular Ultrasound, 5 (1)
  • [47] Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease
    Blok, I. M.
    van Riel, A. C. M. J.
    Schuuring, M. J.
    Duffels, M. G.
    Vis, J. C.
    van Dijk, A. P. J.
    Hoendermis, E. S.
    Mulder, B. J. M.
    Bouma, B. J.
    NETHERLANDS HEART JOURNAL, 2015, 23 (05) : 278 - 284
  • [48] Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery
    Kirbas, Ahmet
    Yalcin, Yalim
    Tanrikulu, Nursen
    Gurer, Onur
    Isik, Omer
    CARDIOLOGY JOURNAL, 2012, 19 (04) : 387 - 394
  • [49] Acute Vasoreactivity Testing With Nicardipine in Patients With Pulmonary Arterial Hypertension
    Saito, Yukihiro
    Nakamura, Kazufumi
    Miyaji, Katsumasa
    Akagi, Satoshi
    Mizoguchi, Hiroki
    Ogawa, Aiko
    Fuke, Soichiro
    Fujio, Hideki
    Kiyooka, Takahiko
    Nagase, Satoshi
    Kohno, Kunihisa
    Morita, Hiroshi
    Kusano, Kengo F.
    Matsubara, Hiromi
    Ohe, Tohru
    Ito, Hiroshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 120 (03) : 206 - 212
  • [50] Hemodynamic Analysis of Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: A Numerical Study of Patient-Specific Models
    Wang, Liping
    Zhang, Mingjie
    Chen, Xi
    Hong, Haifa
    Liu, Jinlong
    Xu, Zhuoming
    Hu, Liwei
    Zhong, Yumin
    Jin, Qichen
    Chen, Lijun
    Zhang, Yuqi
    2018 11TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING, BIOMEDICAL ENGINEERING AND INFORMATICS (CISP-BMEI 2018), 2018,